Evidence map›Paper›PMID 34297894›Full record

SynthesisAndrology2022

Clinical use of hyaluronic acid in andrology: A review.

Alessandro Zucchi, Fabrizio Ildefonso Scroppo, Paolo Capogrosso, Andrea Salonia, Jacopo Duante, Vittorio Bini, Giovanni Liguori, Riccardo Bartoletti

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Andrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Review
  8. Review
  9. Intralesional collagenaseTranslational andrology and urology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alessandro ZucchiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.ORCID 0000-0003-2252-4297
Fabrizio Ildefonso ScroppoDepartment of Urology and Andrology, Ospedale di Circolo and Macchi Foundation, Varese, Italy.
Paolo CapogrossoDepartment of Urology and Andrology, Ospedale di Circolo and Macchi Foundation, Varese, Italy.ORCID 0000-0003-2347-9504
Andrea SaloniaUrology dept., University Vita-Salute San Raffaele, Milan, Italy.ORCID 0000-0002-0595-7165
Jacopo DuanteDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Vittorio BiniDepartment of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, Pisa, Italy.
Giovanni LiguoriDepartment of Urology, Cattinara Hospital, University of Trieste, Trieste, Italy.
Riccardo BartolettiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
University of Pisa · ITOspedale di Circolo e Fondazione Macchi · ITUniversity of Perugia · ITUniversity of Trieste · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyaluronic acid is a glycosaminoglycan widely used in the fields of orthopedics, ophthalmology, and aesthetic medicine due to its significant ability to reduce the synthesis of pro-inflammatory proteins and its activity against oxidative stress, a feature of many degenerative illnesses.

objectivesThe objective of the present review is to provide a comprehensive narrative review of the most recent literature on the use of hyaluronic acid in andrology in order to facilitate the use of this therapeutic device in the common clinical practice of many physicians. Specific conditions covered in the review are Peyronie's disease, premature ejaculation, and penile enlargement. MATERIALS AND

methodsA broad and comprehensive literature search included Medline, EMBASE, and the Cochrane Libraries, with no time restriction up to December 2020 and restricted to English language publications. Unpublished studies were not included. The study was registered as "The role of hyaluronic acid in andrology: A systematic review and meta-analysis" in PROSPERO with the ID CRD42021223416. DISCUSSION AND

conclusionHyaluronic acid is a valid choice for the treatment of Peyronie's disease in terms of the resolution of the acute phase of the disease and of contributing to stabilizing the disease as a bridge to potential surgery. Data, furthermore, suggest that hyaluronic acid is frequently associated with an overall clinical improvement, allowing the patient to resume normal sexual activity. With regard to premature ejaculation, data suggests hyaluronic acid-based treatments were effective in prolonging intra-vaginal ejaculation time. Furthermore, hyaluronic acid was found to be safe and well-tolerated, with main adverse events limited to local discomfort, ecchymosis, papule formation, and glans numbness, all of which were reported to resolve spontaneously. Last, with regard to penile enlargement, the overall perception of experts is that hyaluronic acid may be an extremely well-tolerated compound with potential for application in specific areas of male sexual health that are often neglected as compared to more common, and relatively simpler to treat, conditions.

Indexed as

AndrologyHumansHyaluronic AcidMalePenile DiseasesPenile IndurationPremature EjaculationTreatment OutcomeHyaluronic Acidhyaluronic acidpenile enlargementPeyronie's diseasepremature ejaculation

Identifiers

PMID34297894
PMCPMC9135118
OpenAlexW3184164483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.